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Abstract
Knowledge of bioactive plant-derived polyphenols is growing to such an extent that sci-
ence interest is looking at development of different applications in regenerative medicine 
through new and state-of-the-art tissue engineering technologies. Due to their well-estab-
lished and demonstrated antioxidant and anti-inflammatory beneficial properties, poly-
phenols have been extensively investigated to the extent that they provide benefits to 
different pathological conditions, including cardiovascular and bone diseases, neurode-
generative disorders, and cancer. By taking into account the main molecular pathways of 
polyphenols’ action, we want to focus this chapter on applications of polyphenols in bone-
implant devices. In particular, results of polyphenols’ effects on bone cells and tissues 
following local delivery from innovative biomaterials will be discussed, together with 
preliminary in vivo tests. Purpose of the dissertation is to provide the reader new insights 
into knowledge of polyphenols not only regarding the different molecular mechanisms 
involved in their action but also the biological responses deriving from local applications.
Keywords: polyphenols, bone regeneration, molecular mechanisms, bone-implant 
devices, periodontitis
1. Introduction
Plants and their single parts have been employed, for millennia, for healing purposes alone or 
as adjunct therapy to conventional pharmaceuticals, thanks to their richness in different bio-
active compounds, effective on several biological systems [1]. Among them, polyphenols do 
possess different beneficial properties on health—especially effective on the improvement of 
chronic pathologies such as cardiovascular disease, osteoporosis, diabetes, and neurodegener-
ative disorders—which thus strengthens the interest of scientific community [2]. Osteoporosis 
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is a multifactorial degenerative bone disease characterized by an imbalance between bone-
forming and bone-resorbing factors, due to the interaction between genes involved in the 
normal bone metabolism and different external factors, such as vitamin D deficiency, alcohol 
consumption, smoking, aging, and menopause [3]. Thanks to their wide range of activities 
exerted on different biological levels, polyphenols have been shown to protect the bone sys-
tem, starting from bone mass increase to slowdown of bone turnover, due to their well-known 
combined actions on inflammation, oxidative stress, hormones activity, and aging [4].
In fact, several important molecular pathways involved in bone metabolism are targeted by 
polyphenols, such as the estrogen (E) signaling pathway, the mitogen-activated protein kinase 
(MAPK) cascade, sirtuin 1 (Sirt1), Wnt/β-catenin, TGF-β/BMP, phosphatidylinositol-4,5-bispho-
sphate 3-kinase (PI3K)/Akt, and adenosine monophosphate protein kinase (AMPK) [4].
Nowadays, the interest of scientific community toward these phytochemicals is much more 
increasing, in light of their potential strong clinical impact [5–8], even if the bioavailability 
aspect has to be strongly taken into account. In fact, bioavailability is an important factor 
when talking about polyphenols’ actions, and this is because it is affected by different envi-
ronmental, host and food processing-related elements, as well as the chemical structure itself 
[9]. In addition to bioavailability, the dose is also an aspect to take into consideration and, 
specifically, the dose at which the phenolic compound is effective. The effective dose is nor-
mally different from the ingested dose because, in plants, the common polyphenol chemical 
structure is the esterified form, absorption of which is markedly reduced in human tissues, 
while administration of oral doses at supraphysiological concentrations, which could elicit 
beneficial effects, has been shown to be toxic [10]. Furthermore, the ingested polyphenols can 
conjugate to proteins and polysaccharides, beyond affecting absorption [11]. Many efforts 
have been made to overcome the problems derived from oral intake, and so, controlled topi-
cal application of polyphenols, by nanoparticulate drug delivery systems, for example, could 
represent a new era in bone disease management.
A growing body of evidence suggests a role for phytomolecules, such as polyphenols, in bone 
biology. Molecules such as epigallocatechin-3-gallate (EGCG) from green tea have been posi-
tively associated, by multivariate analysis, to a positive trend of increased total body mineral 
density with tea drinking (p < 0.05) in a cohort of almost 5000 multiethnic postmenopausal 
women [12, 13]. A number of in vitro studies have described polyphenols’ interaction with 
bone regeneration pathways. These molecules have also been investigated as possible ther-
apeutic agents for periodontal inflammation because of their ability to modulate the host 
inflammatory response [14]. The efficacy of these molecules has been shown in the control 
of the bone resorption process by osteoimmunological actions, particularly by means of sys-
temic administration in the diet [15].
The possibility of using molecules of this type for treatment and tissue regeneration in particular 
cases, such as periodontal and peri-implant defects, is obviously of great practical interest [16].
Furthermore, a local use, unlike the systemic approach, could be a solution to overcome some 
issues related to the biological adsorption and to enhance the beneficial action of polyphenolic 
molecules at the resorption site. Different delivery systems have been designed to overcome the 
highly soluble nature and the chemical instability of polyphenols, from polymeric matrices, to 
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surface-coated surfaces, nanoparticles, microemulsions and liposomes. In general, all kinds of 
drug delivery systems composed of bone-targeting moieties and/or carriers with the therapeu-
tic agent to be delivered can be employed [17].
Being local delivery of polyphenols, for bone regeneration, a quite recent theme, first studies 
show, however, promising results in terms of enhancement of bone mass and osteoblast pro-
liferation and reduction of the inflammation-related bone resorptive processes [18].
2. Molecular mechanisms of polyphenols in bone protection
Polyphenols are characterized by different properties, which make them able to exert ben-
eficial actions on several biological systems. Such properties include antioxidation, anti-
inflammation, antiviral, and antiallergenic activity and are mainly due to their chemical 
compositions that vary from a compound class to another. This difference is due to the diverse 
chemical structures that, even though share common phenolic features, vary in both con-
figuration and total number of phenolic hydroxyl groups, able to interact with reactive oxy-
gen species (ROS) and reactive nitrogen species (RNS), thanks to their capacity to donate 
hydrogens [19]. Polyphenols with the B-ring hydroxyl configuration, such as flavonoids, do 
show a significant antioxidant action, which increases along with the total number of OH 
groups and with the presence of the 3,4-catechol structure [20]. As non-enzymatic antioxidant 
molecules, polyphenols do exert their radical-scavenging activity by interrupting free-radical 
chain reactions, such as those involved in lipid peroxidation, thus acting as hydrogen dona-
tors, reducing agents, superoxide radical scavengers, and singlet oxygen quenchers (Figure 1) 
[21]. This ROS-scavenging activity is particularly evident in icaritin (a flavonoid isolated from 
Epimedium pubescens) and phloridzin-mediated mechanisms, involved in reducing superoxide 
generation in osteoclasts [22], and, since ROS are responsible for activation of NF-κB signal-
ing, prevention of ROS production has indirect effects on NFATc1, the master TF for promo-
tion of osteoclastogenesis regulated by the NF-κB pathway. This is the case of curcumin that, 
at 5 μM, does inhibit osteoclast differentiation, by suppressing ROS generation [23].
Furthermore, polyphenols are also metal chelators, in which they have been shown to interact 
with metals, especially Fe and Zn, in a manner depending on their own concentration and on 
the metal concentration [24, 25].
In addition to act as direct antioxidants, polyphenols do contribute to activate and regulate 
antioxidant enzymes, to inhibit oxidases, cyclooxygenases, and other enzymes, such as iNOS, 
involved in radical generation [26], through upregulation of Nrf2, a nuclear factor that con-
tributes to the enhanced production of antioxidant enzymes [27, 28].
Furthermore, catalase (CAT), an enzyme that detoxifies hydrogen peroxide, and superoxide 
dismutase (SOD), the major antioxidant defense system against O2ˉ [29], have been shown to 
be increased in rats after administration of ellagic acid (EA), thus decreasing the level of lipid 
peroxidation and accelerating the healing process after tooth extraction [30, 31]. Subsequent 
elevation of CAT and SOD to heme oxygenase (HO) system activation can be seen with cur-
cumin 10 μM, which upregulates HO-1 expression, important for bone marrow stem cell 
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differentiation in the osteoblastic lineage [32]. Moreover, curcumin dose-dependently (0.5–4 
μM) and resveratrol upregulate the content of the antioxidant enzyme glutathione peroxidase 
(Gpx)-1 in the osteoclast, thus modulating the ROS levels (Figure 1) [33, 34].
Intracellular redox homeostasis is maintained, thanks to the presence of multiple interacting 
molecular pathways involved in the regulation of genes modulated by transcription factors 
(TFs) that contain redox-sensitive cysteine residues at their DNA-binding sites. Among them, 
NF-κB, AP-1, Nrf2, and hypoxia-inducible factor (HIF) are involved in the control of the cell 
life-or-death mechanism [35]. Downregulation of the prostanoid pathway by polyphenols 
also gives a negative contribution to bone resorption: in fact, quercetin, quercitrin, icaritin, 
and phloridzin have been shown to diminish production of prostaglandin E2 (PGE2), through 
downregulation of COX-2 and HIF-1α pathways [36–39].
Since these phytochemicals also showed pro-oxidant activities under certain conditions, and 
in a directly proportional manner to the total number of hydroxyl groups, it may be pos-
sible that activation of antioxidant enzymes occurs in response to this pro-oxidative feature, 
particularly evident in the presence of metals such as Cu and Fe, in cancer cells [40] but not 
in normal cells [41]. Such toxic property determines cytotoxic and pro-apoptotic effects, due 
Figure 1. Molecular signaling mechanisms involved in polyphenol-induced bone protection.
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to ROS-mediated cellular DNA breakage. In cancer cells, copper ions have been shown to 
be significantly elevated, compared to normal cells, and polyphenols are able to mobilizate 
endogenous Cu ions, which then activate a copper-dependent pro-oxidant pathway, leading 
to breakage of the double helix [42]. Epigallocatechin-3-gallate (EGCG) shows cytotoxic prop-
erties on osteoclasts, thanks to its reductive actions on Fe(III) catalyzed through the Fenton 
reaction, leading to production of hydroxyl radicals [43–45].
Antioxidant actions of polyphenols are not only limited to inhibition of bone resorption but 
are also directed at promotion of bone formation, through enhancing survival, function, and 
metabolism of osteoblasts. Specifically, reduction of the apoptosis rate through suppress-
ing p53 signaling in the mitochondrion has been shown to be exerted by proanthocyanidins, 
thanks to their ROS-scavenging actions (Figure 1) [46].
The mitochondrion is the major site of production of ROS and RNS, and with the presence of 
multiple membranes, oxidative stress due to an easy lipid peroxidation is a common fact [47]. 
Furthermore, mitochondrial ROS also play a role in different signaling pathways, primarily 
those involved in cell death and survival signals: for example, mitochondria are essentials 
for the transactivation of growth factor receptor signaling to downstream mitogen-activated 
protein kinases (MAPKs), such as extracellular signal-regulated kinase 1/2 (ERK1/2), C-Jun 
N-terminal kinase (JNK), and p38 [48].
It is thus clear that polyphenols, such as antioxidants, are important bone protectors, thanks 
to their regulation of bone cell proliferation and survival or death [49, 50]. In fact, by decreas-
ing the oxidative status, they do contribute to osteoblast proliferation, activity, and differen-
tiation, through crosstalking with different molecular signaling pathways.
So, activation of MAPK pathway by polyphenols leads to beneficial effects at different levels, 
with promotion of bone anabolism through phosphorylation of ERK, p38, and JNK [51–57], 
reduction of bone resorption, inhibition of osteoclast differentiation, and regulation of bone 
remodeling through suppressing receptor activator of nuclear factor kappa-B (NF-κB) ligand 
(RANKL) (Figure 1) [58–62]. RANKL, expressed by osteoblasts, T cells, and endothelial cells, 
stimulates osteoclast precursors to differentiate in mature osteoclasts, by binding to its cog-
nate receptor, RANK, expressed on the surface of target cells. Binding of RANKL to RANK 
leads to TNF receptor-associated factor (TRAF) 6 recruitment and subsequent MAPK activa-
tion, as well as PI3K and NF-κB [63].
Hence, it is clear that by targeting the main TF of the inflammatory pathway, polyphenols are 
able to influence several processes involved in bone resorption, with inhibition of the expres-
sion of genes, such as interleukin (IL)-1β [64], monocyte chemotactic protein (MCP)-1 [65], 
IL-6 [66], tumor necrosis factor (TNF)-α [67], and matrix metalloproteinases (MMPs) [68], and 
induction of anti-inflammatory cytokines, such as IL-10 [69].
These anti-inflammatory properties have also effect on osteoclast differentiation, with inhibi-
tion of NFATc1 gene expression, thus affecting the early stages of osteoclast differentiation 
[28, 54, 70–74].
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Concerning osteoblastic differentiation, several signaling pathways can be activated by poly-
phenols and, specifically, through transforming growth factor-β (TGF-β)/bone morphoge-
netic protein (BMP), Wnt/β-catenin, phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/
Akt, and the estrogen (E2) pathway. For example, EGCG 5μM has been shown to positively 
act on osteoblast differentiation and mesenchymal stem cell (MSC) proliferation by upregu-
lating BMP2 and runt-related transcription factor 2 (Runx2) expression [75]. Also, myricetin 
is able to promote osteoblast differentiation and activity, by targeting small mother against 
decapentaplegic (SMAD)1/5/8, downstream of BMP signaling [76, 77]. Osteoblast mineral-
ization through upregulation of alkaline phosphatase (ALP) gene expression has also been 
shown to be induced by EGCG 25μM, through activation of β-catenin [78], and by hydroxy-
flavones 20μM, through activation of Akt signaling [57].
Given that polyphenols have also been demonstrated to have estrogen-like biological activi-
ties, it can be argued that they can modulate the estrogen-dependent pathway by acting as 
partial agonists and/or antagonists of the estrogen receptor (ER) in a tissue type and ligand 
concentration-dependent manner [79]. In this context, they do target the classical ER path-
way, by binding to the ER and thus activating the ER-dependent gene transcription leading to 
inhibition of bone resorption and stimulation of osteoblastic bone formation [37, 80, 81], but 
they are also able to exert beneficial effects on bone system through the non-classical estrogen 
pathway, thus eliciting expression of the main osteoblast differentiation genes [82–85].
3. Applications of polyphenols in medicine for bone regeneration
Applications of polyphenols to investigate local bone formation are under current investiga-
tion because of the promising results obtained in the still limited in vitro and in vivo studies.
Different strategies have been considered to overtake the several disadvantages concern-
ing polyphenol bioavailability, stability, and biopharmaceutical properties in general. These 
include different drug delivery systems (DDSs), encapsulation [86], chemical modifica-
tions [87], design of colloidal systems [88], use of nanoparticles [89], and implant surface 
modifications.
DDS can be divided into local and systemic and are characterized by different properties: 
first, local drug delivery is primarily intended for a local controlled effect, with reduction of 
the dose and possible side effects, while systemic delivery has the advantage of non-invasive-
ness, but uncontrollable and non-specific drug release [90].
In the field of bone regeneration, there is a need for the use of local and sustained drug 
release to avoid the risk of possible occurring infections at the site of bone defect. This 
is made possible, thanks to a spatial and temporal controlled drug release, leading to an 
increase in local effectiveness and minimization of toxicity to other tissues [91]. That is 
why biomedical applications for bone tissue regeneration have been employing carrier 
scaffolds, surfaces of which are coated by biodegradable polymer coatings loaded with 
the interested molecule.
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3.1. Development of biomaterials functionalized with polyphenols
Within the wide world of bone regeneration, periodontal regeneration has gained particular 
attention. In the last decade, the development of grafting materials has aroused great interest 
[92–94]. In particular, synthetic ceramic materials, such as tricalcium phosphate and hydroxy-
apatite (HA), have been widely used due to their good reproducibility, biocompatibility, non-
immunogenicity, but especially because of their similarity to the components of the native 
bone mineral phase [95, 96]. The most used materials (bone grafts, scaffolds, bone pastes, 
putties, etc.) available on the market for those applications work mainly through mechanical 
action, providing a functional scaffold for cell adhesion [97–99]. Some other molecules confer 
them a biological action, as they are able to stimulate bone regeneration (osteoinduction). For 
example, bovine bone–based biomaterials are treated to not completely eliminate the organic 
portion, so that the final product still contains collagen molecules, which play a role in the 
promotion of new bone formation [100]. There are also synthetic products containing collagen 
or its sequences, which are designed to favor the interaction with the cellular components 
and, thus, the regeneration process [101, 102].
Furthermore, growth factors and other biological molecules (such as amelogenin) are present 
in some materials commonly used in the sector [103–105].
However, loss of soft tissue and resorption of bone tissue around natural teeth are, in many 
cases, the consequence of a complex infection of bacterial origin, which are known as periodon-
titis (or peri-implantitis if it occurs after the insertion of a titanium implant) [16]. Therefore, 
although the mentioned products are widely used with successful results, the development of 
the scientific knowledge in this field has indicated possible ways of improvement.
For natural reasons, the masticatory apparatus is the interface of a rich in bacteria envi-
ronment and the soft and skeletal tissues. The cells of the immune system are constantly 
stimulated by the contact with the microorganisms and are continuously urged to mount an 
inflammatory response.
Periodontitis is due to a bacterially induced chronic inflammatory disease that destroys the 
connective tissues and the bone that supports the teeth. Tissue destruction occurs following 
the cell death induced by the harmful products derived by the bacterial biofilm and, indi-
rectly, following the activation of inflammatory cells, which produce and release cytokines 
acting as pro-inflammatory and catabolic mediators [106].
It is known that some cytokines produced in response to the inflammatory stimulus, such 
as interleukin 1, have a powerful effect in stimulating the formation of osteoclasts [107–109]. 
Formation of new bone and resorption of the existing bone tissue are normally balanced in the 
body, ensuring the so-called bone homeostasis, but in conditions of prolonged inflammatory 
response, such as those naturally present in the areas where the teeth emerge in the oral cavity 
and in the peri-implant areas, the pro-osteoclastogenic action of cytokines leads to the onset 
of resorption phenomena. These phenomena are favored not only by general factors, such as 
inadequate oral hygiene, but also and especially by individual factors, such as genetic aspects 
in the case of periodontitis or periodontal disease [110–112].
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The common treatment for patients affected by these diseases is the use of a local debridement 
in order to eliminate the residual tissue infected, a surface decontamination and the use of clas-
sical bone grafting material in combination with a systemic antibiotic therapy. Unfortunately, 
this approach is not so effective, due to a specific adhesion of bacteria on the biomaterials and 
to the very low penetration of the antibiotic into the osseous defect [113–115].
Besides stimulation of osteoclastogenesis and bone resorption, prolonged inflammatory stimu-
lation involves destruction of the soft tissue, also because of the so-called oxidative stress, that 
damages tissues as a result of a loss of control of the defence mechanisms that detoxify the organ-
ism from reactive oxygen species (ROS), molecular species generated in inflammatory sites.
The commercially available material currently used in periodontal regeneration has a lack in 
prevention or in controlling the cause of bone resorption. It would be, thus, desirable to pro-
vide an action aimed at controlling specific antiosteoclastogenic actions and effects to prevent 
the damage derived from oxidative stress, by exerting antioxidant properties.
The use of polyphenols as natural molecules to control and enhance periodontal regenera-
tion, particularly in patient affected by periodontitis, is due to their antioxidant, free-radical 
scavenging, and antimicrobial properties.
Polyphenol molecules could be synthesized in laboratory or could be extracted from the 
different plant sources or their residues. Among the wide panorama of the natural sources 
of these molecules, extraction from wastes for ecological, ethical, and economic reasons has 
aroused great interest. One of the most abundant residuals with a high percentage of poly-
phenol content is the grape marc (skin and seeds). Grape, with 63 million of tons of products, 
is one of the most extensively cultivated crops in the world; most of it is used for wine pro-
duction, and the consequence is the creation of almost 10 million of tons of by-products [116]. 
These byproducts represent approximately 20% of the harvested grapes, and they have been 
for long time undervalued; however, in the last decade, many research groups have been 
focused on the potential of the winery pomace as source of polyphenols. It is known in the art 
that polyphenols in complex mixtures may be easily extracted, and in literature, many dif-
ferent techniques are present: classical solvent extraction (using different solvents) [117–121], 
simulated maceration [122], ultrasound-assisted extraction [123], microwave-assisted extrac-
tion [124], and the most recent extraction using supercritical fluid in combination or not with 
solvent [117, 125, 126].
The phenolic composition of the extract from grape seeds and skin has been extensively ana-
lyzed, in terms of quantity and quality [127–129]. Of course, in literature, a wide dispersion 
of data is present, which is due to the fact that the phenolic spectra depend from the enologi-
cal practice and, of course, from the variety of grape. It is possible to list different molecules 
that are present: anthocyanins (in particular for red grape), gallic acid (in particular in seeds), 
epigallocatechin (in skin), hydroxycinnamic acids (in particular in white pomace skin), pro-
anthocyanidins, quercetin, resveratrol, and so on. However, in general, it is possible to assess 
that the most abundant compounds are anthocyandins and flavanols [127].
Procyanidins and proanthocyanidins, complex molecules consisting of different repeating 
units and present in grapes, have been extensively studied in relation to their ability to re-min-
eralize dental tissue and its potential effect to treat periodontal disease [14, 15, 45, 130–135].
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The purpose is to use these molecules for the treatment of specific pathologies, such as peri-
odontitis, in combination with a biomaterial, to locally administrate polyphenols. However, 
such local use is hindered by the high-water solubility of these molecules, which could rap-
idly remove them from the site of implantation. The possibility of local use could be achieved 
if polyphenols were mixed or bonded with a carrier able to exert the effects of the pheno-
lic compounds for a prolonged time, circumventing the problem of the high solubility and 
instability of polyphenols. For examples, the polyphenolic extracts could be combined with 
collagen, exploiting the crosslinking effect exerted by some of these molecules [136], particu-
larly the so-called tannins, which are molecules with high-molecular weight derived from the 
condensation of the repeated units of flavanols [137].
The obtained collagen-gel is stable in aqueous environment and allows a sustained controlled 
local release [138]. The authors suggest to combine it with granular ceramic fillers and to fill 
the peri-implant bone defects. This solution, for example, combines the mechanical scaffolding 
properties with the biological and pro-osteogenic actions of collagen and with an effective and 
locally concentrated anti-inflammatory, antioxidant, and antiosteoclastogenic action of poly-
phenols (see Figure 2) [139]. In vitro assays showed a high antioxidant effect and a controlled 
release of polyphenols (such as gallic acid, proanthocyanidins, catechins, and epicatechins). 
Interesting results show that, in presence of a compound that generates free radicals (sodium 
nitroprusside), the presence of polyphenols released from the bone filler protects the cells. 
Furthermore, osseointegration efficacy was evaluated through animal studies, by implanting 
the material in the medial condyle of the femur bone of rabbits, which showed an increase in 
the percentage of new formed bone area, compared with the bone filler without polyphenols.
The role of polyphenols was also studied to investigate their inhibitory properties on collagen 
degradation caused by collagenase enzymes. In particular, bacteria could enhance the pro-
duction of enzymes that may degrade the collagenous matrix of soft and hard tissues [140]. 
Hence, during inflammation, the over production of collagenase enhances the disruption of 
the supporting tissue [141]. It has also been shown that catechin and epigallocatechin gallate-
treated collagen exhibit between 56 and 95% resistance against collagenolytic hydrolysis by 
collagenases [142, 143]. These kinds of properties could be effective only if polyphenols were 
locally administrated, in order to be directly in contact with the tissue and to protect the col-
lagen matrix from degradation.
MMP-8 (collagenase-2) and MMP-9 (gelatinase-B) are considered the main responsible for col-
lagen degradation in inflamed tissues, for example, during gingivitis and periodontitis. It has 
been demonstrated that bacterial infections increase the expression of those enzymes [144]. 
Those MMPs are produced by Gram (−) periodonto-pathogens and play a crucial role in tissue 
destruction during periodontitis; it has also been demonstrated that grape seed extracts, rich in 
proanthocyanidin molecules, inhibit their activity, suggesting that polyphenol extracts could 
be used in the development of novel strategies for the treatment of periodontitis [14, 135].
The success rate of implant installation depends on the quantity and quality of bone, which 
is present in the extraction site [145, 146]. However, the quality of the new formed bone and 
its osseointegration also depends on the reaction caused by the implant itself. Dental replace-
ment by using titanium dental implants is nowadays a quite common procedure in oral sur-
gery [147]. Millions of dental implants are placed worldwide per year, and this number is 
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expected to increase [148]. Titanium is used not only in dentistry, but also in orthopedics, 
since it is characterized by a bioinertia, which promotes tissue regeneration. Periprosthetic 
infection is a consequence of implant insertion procedures, and it is due to the formation of 
microbial plaque accumulation, which promotes reaction of the inflammatory cells around 
the implant. Furthermore, macrophage cells consider the implant as a foreign body, and thus, 
they act by increasing the expression of pro-inflammatory cytokines and chemokines, which 
lead to the generation of chronic inflammation [113, 149].
Figure 2. Composition for filling bone and periodontal defects combined with polyphenols rich extract. (a) Bone filler 
paste. (b) Scanning electron microscopy of the composite bone filler. (c) Optical image of the bone filler paste during the 
sustained release of polyphenols.
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3.2. Development of Ti surfaces functionalized with polyphenols
In dentistry, research has been focusing its attention on titanium (Ti) implants coated with 
osteoinductive and/or antibacterial agents, thus promising an improvement of the success 
rate of implants [150]. In order to control the post-implantation infection, a stable coating 
bonded on the surface of the implant is much more desirable rather than a releasing form, 
since a stable and durable interface between implant and tissue could avoid biofilm forma-
tion, reduce inflammation, and promote osseointegration.
In this respect, polyphenols, thanks to their well-known antibacterial properties [151, 152], 
are now largely considered in bone regeneration applications and aimed at inhibiting biofilm 
formation [153], as it has been demonstrated, for example, for flavonoids from propolis [154], 
proanthocyanidins [155, 156], and chlorogenic acid [157]. Among all polyphenols, EGCG 
is largely studied for its antibacterial and anti-inflammatory properties, which makes it a 
promising compound to be employed in different treatments [158] and, in particular, for the 
improvement of the periodontal status, through EGCG-containing slow-release local delivery 
systems, such as hydroxypropyl cellulose strips, applied in the periodontal pockets [132].
The inflammatory properties of polyphenols are also an important aspect to take into consider-
ation, because of their potential in playing a role in all the mechanisms that control bone resorp-
tion and, consequently, bone loss. In fact, bone resorption and inflammation are strictly linked, 
as the main inflammatory pathways are also involved in osteoclastogenesis and bone remodel-
ing [159]. Furthermore, a situation of chronic inflammation also leads to a continuous efflux of 
the mediators of inflammation [160], a fact that can be easily observed in ulcers and periodon-
titis. Periodontal disease is a chronic inflammatory disease characterized by the progressive 
destruction of the tooth supporting tissues, following a chronic inflammatory response to the 
accumulation of bacterial plaque on and around the teeth [161]. Therapeutic approaches aimed 
at modulating the host response, did involve polyphenols from Cranberries (Vaccinium macro-
carpon) extracts, and led to beneficial effects slowing the periodontal disease progression [162].
In this field, polyphenols have also been considered for applications [163] in helping to con-
trol the oral hygiene, through the use of toothpastes enriched with 0.1% extracts containing 
naringenin and quercetin [164] and 0.5% extracts containing baicalein, baicalin, and wogonin 
[165] and through the use of polyphenol-containing gels [166].
Direct osteopromotive effects of polyphenols on osteoblast differentiation, proliferation, and 
protection are also well documented, so different bioactive polyphenol-coated biomaterials 
have been engineered, from the development of Ti surfaces functionalized with flavonoids 
[167, 168] conferring them osteopromotive, anti-inflammatory, and antibacterial properties, 
to tea polyphenol-modified calcium phosphate nanoparticles, which have been shown to 
enhance remineralization of preformed enamel lesions on bovine incisors [169].
Modifications of Ti surfaces, with quercitrin nanocoatings, allowed Córdoba et al. to engineer 
a polyphenol-functionalized biomaterial with enhanced mineralization properties, compared 
to Ti surfaces alone [170].
Improvement of hydroxyapatite (HA) deposition has been shown for grade 5 Ti silica-based 
bioactive glasses functionalized with extracts from green tea or red grape skin, making them 
suitable for bone contact applications [171].
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Testing a mixture of 0.2mg EGCG with alpha tricalcium phosphate particles in rat calvarial 
defects has led to encouraging results of enhancement of bone formation [172], while conjuga-
tion of 4.2μg EGCG with a gel showed ability to induce differentiation of a mouse mesenchy-
mal stem cell line toward the osteoblast lineage [18].
Employ of scaffolds enriched with polyphenols is, thus, considered as a promising tool for 
bone regeneration bioengineering, as functionalization of scaffold surface with polyphenols 
increases the bone regeneration ability, compared to a scaffold alone [173, 174]. Biodegradable 
soybean-based biomaterials (SBs), in a granulated form, have been employed as bone filler, 
in vitro, to investigate the biological properties for bone applications. Specifically, inhibition 
of osteoclast activation following incubation with SB has been observed, with a parallel inhib-
itory effect on monocyte/macrophage activity and, thus, a general anti-inflammatory action 
ascribed to the two main soy phytoestrogens genistein and daidzein. Furthermore, SBs have 
also been shown to induce mineralization in osteoblasts in vitro [175]. The same group of 
researchers then investigated the morphology of bone in response to SB granules in rabbits, 
and confirming the previous in vitro experiment [175], they showed bone repair with features 
distinct from that associated with sham-operated non-treated defects [176].
Widely used in a bone regeneration context, hydrogels do show many advantages compared 
to other kinds of scaffolds [177] because they can easily encapsulate bioactive substances, 
such as polyphenols too, which are able to induce mineralization. Increase of mineraliza-
tion, through the use of gellan gum (GG) hydrogels enriched with Seanol®, an antioxidative 
food supplement containing Ecklonia cava-derived phlorotannins, has been observed in vitro 
[178], even if in some cases, the mineralization process has not been observed [179].
Lack of statistical differences, following implantation of a combination of a bovine-derived 
HA and Cissus quadrangularis extracts, has been also observed in a clinical trial involving 20 
patients with intrabony defects [180]. Among the several medicinal plants exhibiting osteopro-
tective properties, safflower (Carthamus tinctorius) has been investigated in light of its numer-
ous beneficial effects on bone formation, and, in particular, its seed extracts (SSE) have been 
combined with a collagen sponge (SSE/Col) functioning as a bone filler for the regeneration 
of periodontal tissue in beagle dogs. Results, at 8-week, showed increase of bone formation in 
the groups having received the SSE/Col, compared to control groups [181]. The same results 
of bone regeneration on dogs have been showed, by the same authors, after implantation of a 
polylactide glycolic acid bioabsorbable barrier membrane (PLGA) containing SSE [182].
4. Conclusions
Thanks to their demonstrated multiple health beneficial properties, polyphenols are increas-
ingly considered for employ in different fields, from medicine, to nutraceutical and cosme-
ceutical industries. That is why the general interest, particularly in the field of medicine, is 
drawing attention to the development of next-generation biomaterials, functionalized with 
bioactive molecules, such as polyphenols. Thanks to the obtained promising results, polyphe-
nol-containing bone designed biomaterials could represent a new era in bone disease man-
agement, with a high impact on bone regeneration quality.
Polyphenols82
Conflict of interest
Two of the authors (CC and MM) own shares of Nobil Bio Ricerche srl, while ET and GI are 
Nobil Bio Ricerche employees. The company is involved in R&D of polyphenol-containing 
bone-implant devices for commercial use.
Author details
Elisa Torre, Giorgio Iviglia, Clara Cassinelli and Marco Morra*
*Address all correspondence to: mmorra@nobilbio.it
Nobil Bio Ricerche srl, Portacomaro (AT), Italy
References
[1] Wachtel-Galor S, Benzie IFF Herbal Medicine: An Introduction to its History, Usage, 
Regulation, Current Trends, and Research Needs. 2011
[2] Ganesan K, Xu B. A critical review on polyphenols and health benefits of black soybeans. 
Nutrients. 2017;9:1-17. DOI: 10.3390/nu9050455
[3] Marini F, Brandi ML. Genetic determinants of osteoporosis: Common bases to cardio-
vascular diseases? International Journal of Hypertension. 2010;2010:1-16. DOI: 10.4061/ 
2010/394579
[4] Torre E. Molecular signaling mechanisms behind polyphenol-induced bone anabolism. 
Phytochemistry Reviews. 2017;16:1183-1226. DOI: 10.1007/s11101-017-9529-x
[5] Byberg L, Bellavia A, Larsson SC, Orsini N, Wolk A, Michaëlsson K. Mediterranean diet 
and hip fracture in Swedish men and women. Journal of Bone and Mineral Research. 
2016;31:2098-2105. DOI: 10.1002/jbmr.2896
[6] García-Gavilán JF, Bulló M, Canudas S, Martínez-González MA, Estruch R, Giardina 
S, Fitó M, Corella D, Ros E, Salas-Salvadó J. Extra virgin olive oil consumption reduces 
the risk of osteoporotic fractures in the PREDIMED trial. Clinical Nutrition. 2017. DOI: 
10.1016/j.clnu.2016.12.030
[7] Lambert MNT, Thybo CB, Lykkeboe S, Rasmussen LM, Frette X, Christensen LP, 
Jeppesen PB. Combined bioavailable isoflavones and probiotics improve bone status 
and estrogen metabolism in postmenopausal osteopenic women: A randomized con-
trolled trial. The American Journal of Clinical Nutrition. 2017;106:909-920. DOI: 10.3945/
ajcn.117.153353
[8] Filip R, Possemiers S, Heyerick A, Pinheiro I, Raszewski G, Davicco MJ, Coxam V. Twelve-
month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, 
Potentials of Polyphenols in Bone-Implant Devices
http://dx.doi.org/10.5772/intechopen.76319
83
randomized trial increases serum total osteocalcin levels and improves serum lipid pro-
files in postmenopausal women with osteopenia. The Journal of Nutrition, Health & 
Aging;19(2014):77-86. DOI: 10.1007/s12603-014-0480-x
[9] D’Archivio M, Filesi C, Varì R, Scazzocchio B, Masella R. Bioavailability of the polyphenols: 
Status and controversies. International Journal of Molecular Sciences. 2010;11:1321-1342. 
DOI: 10.3390/ijms11041321
[10] Mennen LI, Walker R, Bennetau-Pelissero C, Scalbert A. Risks and safety of polyphenol 
consumption. The American Journal of Clinical Nutrition. 2005;81:326-329. doi: 81/1/ 
326S [pii]
[11] Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: Food sources and 
bioavailability. The American Journal of Clinical Nutrition. 2004;79:727-747
[12] Nakamura H, Ukai T, Yoshimura A, Kozuka Y, Yoshioka H, Yoshinaga Y, Abe Y, Hara Y. 
Green tea catechin inhibits lipopolysaccharide-induced bone resorption in vivo. Journal 
of Periodontal Research. 2010;45:23-30. DOI: 10.1111/j.1600-0765.2008.01198.x
[13] Tominari T, Matsumoto C, Watanabe K, Hirata M, Grundler FMW, Miyaura C, Inada M. 
Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced inflamma-
tory bone resorption, and protects against alveolar bone loss in mice. FEBS Open Bio. 
2015;5:522-527. DOI: 10.1016/j.fob.2015.06.003
[14] Govindaraj J, Emmadi P, Puvanakrishnan R. In vitro studies on inhibitory effect of 
proanthocyanidins in modulation of neutrophils and macrophages. Indian Journal of 
Biochemistry & Biophysics. 2010;47:141-147
[15] Govindaraj J, Emmadi P, Deepalakshmi V, Rajaram G, Prakash R. Puvanakrishnan, pro-
tective effect of proanthocyanidins on endotoxin induced experimental periodontitis in 
rats, Indian. The Journal of Experimental Biology. 2010;48:133-142
[16] Govindaraj J, Emmadi P, Puvanakrishnan R. Therapeutic effects of proanthocyanidins 
on the pathogenesis of periodontitis--an overview. Indian Journal of Experimental 
Biology. 2011;49:83-93 http://www.ncbi.nlm.nih.gov/pubmed/21428209
[17] Wang D, Miller SC, Kopečková P, Kopeček J. Bone-targeting macromolecular thera-
peutics. Advanced Drug Delivery Reviews. 2005;57:1049-1076. DOI: 10.1016/j.addr. 
2004.12.011
[18] Honda Y, Tanaka T, Tokuda T, Kashiwagi T, Kaida K, Hieda A, Umezaki Y, Hashimoto Y, 
Imai K, Matsumoto N, Baba S, Shimizutani K. Local controlled release of polyphenol 
conjugated with gelatin facilitates bone formation. International Journal of Molecular 
Sciences. 2015;16:14143-14157. DOI: 10.3390/ijms160614143
[19] Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010;2:1231-
1246. DOI: 10.3390/nu2121231
[20] Sekher Pannala A, Chan TS, O’Brien PJ, Rice-Evans CA. Flavonoid B-ring chemistry 
and antioxidant activity: Fast reaction kinetics. Biochemical and Biophysical Research 
Communications. 2001;282:1161-1168. DOI: 10.1006/bbrc.2001.4705
Polyphenols84
[21] Carocho M, Ferreira ICFR. A review on antioxidants, prooxidants and related contro-
versy: Natural and synthetic compounds, screening and analysis methodologies and 
future perspectives. Food and Chemical Toxicology. 2013;51:15-25. DOI: 10.1016/j.
fct.2012.09.021
[22] Huang J, Yuan L, Wang X, Zhang T-L, Wang K. Icaritin and its glycosides enhance osteo-
blastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sciences. 2007; 
81:832-840. DOI: 10.1016/j.lfs.2007.07.015
[23] Moon HJ, Ko WK, Han SW, Kim DS, Hwang YS, Park HK, Kwon IK. Antioxidants, 
like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by sup-
pressing reactive oxygen species generation. Biochemical and Biophysical Research 
Communications. 2012;418:247-253. DOI: 10.1016/j.bbrc.2012.01.005
[24] Cherrak SA, Mokhtari-Soulimane N, Berroukeche F, Bensenane B, Cherbonnel A, Mer-
zouk H, Elhabiri M. In vitro antioxidant versus metal ion chelating properties of flavo-
noids: A structure-activity investigation. PLoS One. 2016;11:1-21. DOI: 10.1371/journal.
pone.0165575
[25] Hider RC, Liu ZD, Khodr HH. Metal chelation of polyphenols. Methods in Enzymology. 
2001;335:190-203. DOI: 10.1016/S0076-6879(01)35243-6
[26] Procházková D, Boušová I, Wilhelmová N. Antioxidant and prooxidant properties of 
flavonoids. Fitoterapia. 2011;82:513-523. DOI: 10.1016/j.fitote.2011.01.018
[27] Lee SH, Kim JK, Jang HD. Genistein inhibits osteoclastic differentiation of RAW 264.7 
cells via regulation of ROS production and scavenging. International Journal of Mole-
cular Sciences. 2014;15:10605-10621. DOI: 10.3390/ijms150610605
[28] Sakai E, Shimada-Sugawara M, Yamaguchi Y, Sakamoto H, Fumimoto R, Fukuma Y, 
Nishishita K, Okamoto K, Tsukuba T. Fisetin inhibits osteoclastogenesis through pre-
vention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase 
II antioxidant enzymes. Journal of Pharmacological Sciences. 2013;121:288-298. DOI: 
10.1254/jphs.12243FP
[29] Fukai T, Ushio-Fukai M. Superoxide dismutases: Role in redox signaling, vascular func-
tion, and diseases. Antioxidants & Redox Signaling. 2011;15:1583-1606. DOI: 10.1089/
ars.2011.3999
[30] Al-Obaidi MMJ, Al-Bayaty FH, Al Batran R, Hassandarvish P, Rouhollahi E. Protective 
effect of ellagic acid on healing alveolar bone after tooth extraction in rat-a histologi-
cal and immunohistochemical study. Archives of Oral Biology. 2014;59:987-999. DOI: 
10.1016/j.archoralbio.2014.06.001
[31] Al-Obaidi MMJ, Al-Bayaty FH, Al Batran R, Hassandarvish P, Rouhollahi E. Impact of 
ellagic acid in bone formation after tooth extraction: An experimental study on diabetic 
rats. Archives of Oral Biology. 2014;59:987-999. DOI: 10.1016/j.archoralbio.2014.06.001
[32] Gu Q, Cai Y, Huang C, Shi Q, Yang H. Curcumin increases rat mesenchymal stem 
cell osteoblast differentiation but inhibits adipocyte differentiation. Pharmacognosy 
Magazine. 2012;8:202-208. DOI: 10.4103/0973-1296.99285
Potentials of Polyphenols in Bone-Implant Devices
http://dx.doi.org/10.5772/intechopen.76319
85
[33] Kim WK, Ke K, Sul OJ, Kim HJ, Kim SH, Lee MH, Kim HJ, Kim SY, Chung HT, Choi HS. 
Curcumin protects against ovariectomy-induced bone loss and decreases osteoclasto-
genesis. Journal of Cellular Biochemistry. 2011;112:3159-3166. DOI: 10.1002/jcb.23242
[34] Zhao L, Wang Y, Wang Z, Xu Z, Zhang Q, Yin M. Effects of dietary resveratrol on 
excess-iron-induced bone loss via antioxidative character. The Journal of Nutritional 
Biochemistry. 2015;26:1174-1182. DOI: 10.1016/j.jnutbio.2015.05.009
[35] Trachootham D, Lu W, a Ogasawara M, Nilsa R-DV, Huang P. Redox regulation of cell 
survival. Antioxidants & Redox Signaling. 2008;10:1343-1374. DOI: 10.1089/ars.2007.1957
[36] Hsieh T-P, Sheu S-Y, Sun J-S, Chen M-H. Icariin inhibits osteoclast differentiation and 
bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE2 synthe-
sis. Phytomedicine. 2011;18:176-185. DOI: 10.1016/j.phymed.2010.04.003
[37] Puel C, a Quintin JM, Obled C, Davicco MJ, Lebecque P, Kati-Coulibaly S, Horcajada MN, 
Coxam V. Prevention of bone loss by phloridzin, an apple polyphenol, in ovariectomized 
rats under inflammation conditions. Calcified Tissue International. 2005;77:311-318. 
DOI: 10.1007/s00223-005-0060-5
[38] Guo C, Hou G, Li X, Xia X, Liu D, Huang D, Du S. Quercetin triggers apoptosis of lipo-
polysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 
cells. Cellular Physiology and Biochemistry. 2012:123-136
[39] Gómez-Florit M, Monjo M, Ramis JM. Quercitrin for periodontal regeneration: Effects 
on human gingival fibroblasts and mesenchymal stem cells. Scientific Reports. 2015:1-9. 
DOI: 10.1038/srep16593
[40] Eghbaliferiz S, Iranshahi M. Prooxidant activity of polyphenols, flavonoids, anthocyanins 
and carotenoids: Updated review of mechanisms and catalyzing metals. Phytotherapy 
Research. 2016;1391:1379-1391. DOI: 10.1002/ptr.5643
[41] Khan HY, Zubair H, Ullah MF, Ahmad A, Hadi SM. A Prooxidant mechanism for the 
anticancer and Chemopreventive properties of plant polyphenols. Current Drug Targets. 
2012;2012. DOI: 10.2174/138945012804545560
[42] Khan HY, Zubair H, Faisal M, Ullah MF, Farhan M, Sarkar FH, Ahmad A, Hadi SM. Plant 
polyphenol induced cell death in human cancer cells involves mobilization of intracellu-
lar copper ions and reactive oxygen species generation: A mechanism for cancer chemo-
preventive action. Molecular Nutrition & Food Research. 2014;58:437-446. DOI: 10.1002/
mnfr.201300417
[43] Islam S, Islam N, Kermode T, Johnstone B, Mukhtar H, Moskowitz RW, Goldberg VM, 
Malemud CJ, Haqqi TM. Involvement of caspase-3 in epigallocatechin-3-gallate-
mediated apoptosis of human chondrosarcoma cells. Biochemical and Biophysical 
Research Communications. 2000;270:793-797. DOI: 10.1006/bbrc.2000.2536
[44] Nakagawa H, Wachi M, Woo J-T, Kato M, Kasai S, Takahashi F, Lee I-S, Nagai K. Fenton 
reaction is primarily involved in a mechanism of (−)-Epigallocatechin-3-gallate to 
induce osteoclastic cell death. Biochemical and Biophysical Research Communications. 
2002;292:94-101. DOI: 10.1006/bbrc.2002.6622
Polyphenols86
[45] Yun JH, Kim CS, Cho KS, Chai JK, Kim CK, Choi SH. (−)-Epigallocatechin gallate induces 
apoptosis, via caspase activation, in osteoclasts differentiated from RAW 264.7 cells. 
Journal of Periodontal Research. 2007;42:212-218. DOI: JRE935 [pii]\n10.1111/j.1600-
0765.2006.00935.x [doi]
[46] Zhang Z, Zheng L, Zhao Z, Shi J, Wang X, Huang J. Grape seed proanthocyanidins inhibit 
H
2
O
2
-induced osteoblastic MC3T3-E1 cell apoptosis via ameliorating H
2
O
2
-induced 
mitochondrial dysfunction. The Journal of Toxicological Sciences. 2014;39:803-813
[47] Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A. Free radicals, mitochondria, and 
oxidized lipids: The emerging role in signal transduction in vascular cells. Circulation 
Research. 2006;99:924-932. DOI: 10.1161/01.RES.0000248212.86638.e9
[48] Chen K, Thomas SR, Albano A, Murphy MP, Keaney JF. Mitochondrial function is 
required for hydrogen peroxide-induced growth factor receptor transactivation and 
downstream signaling. The Journal of Biological Chemistry. 2004;279:35079-35086. DOI: 
10.1074/jbc.M404859200
[49] Braun KF, Ehnert S, Freude T, Egaña JT, Schenck TL, Buchholz A, Schmitt A, Siebenlist S, 
Schyschka L, Neumaier M, Stöckle U, Nussler AK. Quercetin protects primary human 
osteoblasts exposed to cigarette smoke through activation of the antioxidative enzymes 
HO-1 and SOD-1. Scientific World Journal. 2011;11:2348-2357. DOI: 10.1100/2011/471426
[50] Choi SW, Son YJ, Yun JM, Kim SH. Fisetin inhibits osteoclast differentiation via downreg-
ulation of p38 and c-Fos-NFATc1 signaling pathways. Evidence-Based Complementary 
and Alternative Medicine. 2012;2012. DOI: 10.1155/2012/810563
[51] Qin S, Zhou W, Liu S, Chen P, Wu H. Icariin stimulates the proliferation of rat bone mes-
enchymal stem cells via ERK and p38 MAPK signaling. International Journal of Clinical 
and Experimental Medicine. 2015;8:7125-7133
[52] Zhang X, Zhou C, Zha X, Xu Z, Li L, Liu Y, Xu L, Cui L, Xu D, Zhu B. Apigenin promotes 
osteogenic differentiation of human mesenchymal stem cells through JNK and p38 
MAPK pathways. Molecular and Cellular Biochemistry. 2015;407:41-50. DOI: 10.1007/
s11010-015-2452-9
[53] Bhargavan B, Gautam AK, Singh D, Kumar A, Chaurasia S, Tyagi AM, Yadav DK, Mishra JS, 
Singh AB, Sanyal S, Goel A, Maurya R, Chattopadhyay N. Methoxylated isoflavones, 
cajanin and isoformononetin, have non-estrogenic bone forming effect via differential 
mitogen activated protein kinase (MAPK) signaling. Journal of Cellular Biochemistry. 
2009;108:388-399. DOI: 10.1002/jcb.22264
[54] Lee J-W, Ahn J-Y, Hasegawa S-I, Cha B-Y, Yonezawa T, Nagai K, Seo H-J, Jeon W-B, 
Woo J-T. Inhibitory effect of luteolin on osteoclast differentiation and function. 
Cytotechnology. 2009;61:125-134. DOI: 10.1007/s10616-010-9253-5
[55] Tokuda H, Takai S, Matsushima-Nishiwaki R, Akamatsu S, Hanai Y, Hosoi T, Harada A, 
Ohta T, Kozawa O. (−)-Epigallocatechin gallate enhances prostaglandin F2α-induced 
VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts. Journal of Cellular 
Biochemistry. 2007;100:1146-1153. DOI: 10.1002/jcb.21104
Potentials of Polyphenols in Bone-Implant Devices
http://dx.doi.org/10.5772/intechopen.76319
87
[56] Natsume H, Adachi S, Takai S, Tokuda H, Matsushima-Nishiwaki R, Minamitani C, 
Yamauchi J, Kato K, Mizutani J, Kozawa O, Otsuka T. (−)-Epigallocatechin gallate attenu-
ates the induction of HSP27 stimulated by sphingosine 1-phosphate via suppression 
of phosphatidylinositol 3-kinase/Akt pathway in osteoblasts. International Journal of 
Molecular Medicine. 2009;24:197-203. DOI: 10.3892/ijmm
[57] Lai C-H, Wu Y-W, Yeh S-D, Lin Y-H, Tsai Y-H. Effects of 6-Hydroxyflavone on osteoblast 
differentiation in MC3T3-E1 cells. Evidence-based Complementary and Alternative 
Medicine. 2014;2014:924560. DOI: 10.1155/2014/924560
[58] Lai YL, Yamaguchi M. Phytocomponent p-hydroxycinnamic acid stimulates bone forma-
tion and inhibits bone resorption in rat femoral tissues in vitro. Molecular and Cellular 
Biochemistry. 2006;292:45-52. DOI: 10.1007/s11010-006-9175-x
[59] Yamaguchi M, Weitzmann MN. The bone anabolic carotenoids p-hydroxycinnamic 
acid and beta-cryptoxanthin antagonize NF-kB activation in MC3T3 preosteoblasts. 
Molecular Medicine Reports. 2009;1:641-644. DOI: 10.3892/mmr_00000150
[60] Natarajan K, Singh S, Burke TR, Grunberger D, Aggarwal BB. Caffeic acid phenethyl 
ester is a potent and specific inhibitor of activation of nuclear transcription factor 
NF-kappa B. Proceedings of the National Academy of Sciences. 1996;93:9090-9095. DOI: 
10.1073/pnas.93.17.9090
[61] Bharti a C, Takada Y, Aggarwal BB. Curcumin (Diferuloylmethane) inhibits receptor 
activator of NF-κB ligand-induced NF-κB activation in osteoclast precursors and sup-
presses osteoclastogenesis. Journal of Immunology. 2004;172:5940-5947. DOI: 10.4049/
jimmunol.172.10.5940
[62] Bharti A, Donato N. Curcumin (diferuloylmethane) down-regulates the constitutive acti-
vation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading 
to suppression of proliferation and induction of apoptosis. Blood. 2003;101:1053-1062. 
DOI: 10.1182/blood-2002-05-1320.Supported
[63] Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclas-
togenesis and bone disease. Trends in Molecular Medicine. 2006;12:17-25. DOI: 10.1016/j.
molmed.2005.11.007
[64] La VD, Tanabe S, Grenier D. Naringenin inhibits human osteoclastogenesis and osteo-
clastic bone resorption. Journal of Periodontal Research. 2009;44:193-198. DOI: 10.1111/ 
j.1600-0765.2008.01107.x
[65] Band yopadhyay S, Lion JM, Mentaverri R, Ricupero D a, Kamel S, Romero JR, 
Chattopadhyay N. Attenuation of osteoclastogenesis and osteoclast function by api-
genin. Biochemical Pharmacology. 2006;72:184-197. DOI: 10.1016/j.bcp.2006.04.018
[66] Pang JL, a Ricupero D, Huang S, Fatma N, Singh DP, Romero JR, Chattopadhyay 
N. Differential activity of kaempferol and quercetin in attenuating tumor necrosis fac-
tor receptor family signaling in bone cells. Biochemical Pharmacology. 2006;71:818-826. 
DOI: 10.1016/j.bcp.2005.12.023
Polyphenols88
[67] Zhou T, Chen D, Li Q, Sun X, Song Y, Wang C. Curcumin inhibits inflammatory 
response and bone loss during experimental periodontitis in rats. Acta Odontologica 
Scandinavica. 2013;71:349-356. DOI: 10.3109/00016357.2012.682092
[68] La VD, Howell AB, Grenier D. Cranberry proanthocyanidins inhibit MMP production 
and activity. Journal of Dental Research. 2009;88:627-632. DOI: 10.1177/0022034509339487
[69] Comalada M, Ballester I, Bailón E, Sierra S, Xaus J, Gálvez J, De Medina FS, Zarzuelo 
A. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse 
macrophages by naturally occurring flavonoids: Analysis of the structure-activity rela-
tionship. Biochemical Pharmacology. 2006;72:1010-1021. DOI: 10.1016/j.bcp.2006.07.016
[70] Kim JH, Kim K, Jin HM, Song I, Youn BU, Lee J, Kim N. Silibinin inhibits osteoclast dif-
ferentiation mediated by TNF family members. Molecules and Cells. 2009;28:201-207. 
DOI: 10.1007/s10059-009-0123-y
[71] Kavitha CV, Deep G, Gangar SC, Jain AK, Agarwal C, Agarwal R. Silibinin inhibits pros-
tate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, 
and AP-1 activation in RAW264.7 cells. Molecular Carcinogenesis. 2014;53:169-180. DOI: 
10.1002/mc.21959
[72] Shin DK, Kim MH, Lee SH, Kim TH, Kim SY. Inhibitory effects of luteolin on titanium 
particle-induced osteolysis in a mouse model. Acta Biomaterialia. 2012;8:3524-3531. 
DOI: 10.1016/j.actbio.2012.05.002
[73] Kim T-H, Jung JW, Ha BG, Hong JM, Park EK, Kim H-J, Kim S-Y. The effects of luteolin 
on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. The 
Journal of Nutritional Biochemistry. 2011;22:8-15. DOI: 10.1016/j.jnutbio.2009.11.002
[74] Uchiyama S, Yamaguchi M. Genistein and zinc synergistically stimulate apoptotic cell 
death and suppress RANKL signaling-related gene expression in osteoclastic cells. 
Journal of Cellular Biochemistry. 2007;101:529-542. DOI: 10.1002/jcb.21208
[75] Jin P, Wu H, Xu G, Zheng L, Zhao J. Epigallocatechin-3-gallate (EGCG) as a pro-osteo-
genic agent to enhance osteogenic differentiation of mesenchymal stem cells from 
human bone marrow: An in vitro study. Cell and Tissue Research. 2014;356:381-390. 
DOI: 10.1007/s00441-014-1797-9
[76] Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J. Activation of p38 
mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their 
implication in the stimulation of osteoblastic cell differentiation. Journal of Bone and 
Mineral Research. 2003;18:2060-2068. DOI: 10.1359/jbmr.2003.18.11.2060
[77] Hsu Y-LL, Chang J-KK, Tsai C-HH, Chien T-TTC, Kuo P-LL. Myricetin induces human 
osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated 
protein kinase pathway. Biochemical Pharmacology. 2007;73:504-514. DOI: 10.1016/j.
bcp.2006.10.020
[78] Mount JG, Muzylak M, Allen S, Althnaian T, McGonnell IM, Price JS. Evidence that the 
canonical Wnt signalling pathway regulates deer antler regeneration. Developmental 
Dynamics. 2006;235:1390-1399. DOI: 10.1002/dvdy.20742
Potentials of Polyphenols in Bone-Implant Devices
http://dx.doi.org/10.5772/intechopen.76319
89
[79] Moutsatsou P. The spectrum of phytoestrogens in nature: Our knowledge is expanding. 
Hormones (Athens, Greece). 2007;6:173-193
[80] Wattel A, Kamel S, Mentaverri R, Lorget F, Prouillet C, Petit J, Fardelonne P, Brazier M. 
Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on 
in vitro osteoclastic bone resorption. Biochemical Pharmacology. 2003;65:35-42. DOI: 
10.1016/S0006-2952(02)01445-4
[81] Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Rémésy C, Barlet JP. Rutin 
inhibits ovariectomy-induced osteopenia in rats. Journal of Bone and Mineral Research. 
2000;15:2251-2258. DOI: 10.1359/jbmr.2000.15.11.2251
[82] Xiao H-H, Gao Q-G, Zhang Y, Wong K-C, Dai Y, Yao X-S, Wong M-S. Vanillic acid 
exerts oestrogen-like activities in osteoblast-like UMR 106 cells through MAP kinase 
(MEK/ERK)-mediated ER signaling pathway. The Journal of Steroid Biochemistry and 
Molecular Biology. 2014;144(Pt B):382-391. DOI: 10.1016/j.jsbmb.2014.08.002
[83] Xiao H-H, Fung C-Y, Mok S-K, Wong K-C, Ho M-X, Wang X-L, Yao X-S, Wong M-S. 
Flavonoids from Herba epimedii selectively activate estrogen receptor alpha (ERα) 
and stimulate ER-dependent osteoblastic functions in UMR-106 cells. The Journal 
of Steroid Biochemistry and Molecular Biology. 2014;143C:141-151. DOI: 10.1016/j.
jsbmb.2014.02.019
[84] Song L, Zhao J, Zhang X, Li H, Zhou Y. Icariin induces osteoblast proliferation, dif-
ferentiation and mineralization through estrogen receptor-mediated ERK and JNK 
signal activation. European Journal of Pharmacology. 2013;714:15-22. DOI: 10.1016/j.
ejphar.2013.05.039
[85] Khan K, Pal S, Yadav M, Maurya R, Trivedi AK, Sanyal S, Chattopadhyay N. Prunetin 
signals via G-protein-coupled receptor, GPR30(GPER1): Stimulation of adenylyl cyclase 
and cAMP-mediated activation of MAPK signaling induces Runx2 expression in osteo-
blasts to promote bone regeneration. The Journal of Nutritional Biochemistry. 2015;30:1-
11. DOI: 10.1016/j.jnutbio.2015.07.021
[86] Munin A, Edwards-Lévy F. Encapsulation of natural polyphenolic compounds; a review. 
Pharmaceutics. 2011;3(4):793-829. DOI: 10.3390/pharmaceutics3040793
[87] García DE, Glasser WG, Pizzi A, Paczkowski SP, Laborie M-P. Modification of con-
densed tannins: From polyphenol chemistry to materials engineering. New Journal of 
Chemistry. 2016;40:36-49. DOI: 10.1039/C5NJ02131F
[88] Patel AR, Seijen-ten-Hoorn J, Velikov KP. Colloidal complexes from associated water sol-
uble cellulose derivative (methylcellulose) and green tea polyphenol (Epigallocatechin 
gallate). Journal of Colloid and Interface Science. 2011;364:317-323. DOI: 10.1016/j.
jcis.2011.08.054
[89] Srinivas PR, Philbert M, Vu TQ, Huang Q, Kokini JL, Saos E, Chen H, Peterson CM, 
Friedl KE, Mcdade-ngutter C, Hubbard V, Starke-reed P, Miller N, Betz JM, Dwyer J, 
Milner J, Ross SA. Nanotechnology research: Applications in nutritional sciences. The 
Journal of Nutrition. 2010:119-124. DOI: 10.3945/jn.109.115048.119
Polyphenols90
[90] Weiser J. Controlled release for local delivery of drugs: Barriers and models. Journal of 
Controlled Release. 2008;29:1883-1889. DOI: 10.3174/ajnr.A1256.Functional
[91] Newman MR, Benoit DSW. Local and targeted drug delivery for bone regeneration. 
Current Opinion in Biotechnology. 2016;40:125-132. DOI: 10.1016/j.copbio.2016.02.029
[92] Stevens MM. Biomaterials for bone tissue engineering. Materials Today. 2008;11:18-25. 
DOI: 10.1016/S1369-7021(08)70086-5
[93] Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: An update. Injury. 
2005;36(Suppl 3):S20-S27. DOI: 10.1016/j.injury.2005.07.029
[94] Finkemeier CG. Bone-grafting and bone-graft substitutes. The Journal of Bone and 
Joint Surgery. American Volume. 2002;84–A:454-464
[95] Tadic D. A thorough physicochemical characterisation of 14 calcium phosphate-based 
bone substitution materials in comparison to natural bone. Biomaterials. 2004;25:987-
994. DOI: 10.1016/S0142-9612(03)00621-5
[96] Yuan H, Yang Z, Li Y, Zhang X, De Bruijn JD, De Groot K. Osteoinduction by calcium 
phosphate biomaterials. Journal of Materials Science. Materials in Medicine. 1998;9:723-
726. DOI: 10.1023/A:1008950902047
[97] Ramseier CA, Rasperini G, Batia S, Giannobile WV. Advanced reconstructive technolo-
gies for periodontal tissue repair. Periodontology 2000. 2012;2000(59):185-202. DOI: 
10.1111/j.1600-0757.2011.00432.x
[98] Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL. Regeneration of periodontal 
tissue: Bone replacement grafts. Dental Clinics of North America. 2010;54:55-71. DOI: 
10.1016/j.cden.2009.09.003
[99] Kao RT, Nares S, Reynolds MA. Periodontal regeneration of Intrabony defects: A sys-
tematic review. Journal of Periodontology. 2014;5:1-40. DOI: 10.1902/jop.2015.130685
[100] Richardson CR, Mellonig JT, a Brunsvold M, McDonnell HT, Cochran DL. Clinical 
evaluation of bio-Oss: A bovine-derived xenograft for the treatment of periodontal 
osseous defects in humans. Journal of Clinical Periodontology. 1999;26:421-428. DOI: 
10.1034/j.1600-051X.1999.260702.x
[101] Morra M, Giavaresi G, Sartori M, Ferrari A, Parrilli A, Bollati D, Baena RRY, Cassinelli 
C, Fini M. Surface chemistry and effects on bone regeneration of a novel biomimetic 
synthetic bone filler. Journal of Materials Science. Materials in Medicine. 2015;26:159. 
DOI: 10.1007/s10856-015-5483-6
[102] Iviglia G, Morra M, Cassinelli C, Torre E, Rodriguez Y Baena R. New collagen-coated 
calcium phosphate synthetic bone filler (Synergoss ® ): A comparative surface analysis. 
International Journal of Applied Ceramic Technology. 2018. DOI: 10.1111/ijac.12854
[103] Zhang Y, Wang Y, Shi B, Cheng X. A platelet-derived growth factor releasing chitosan/
coral composite scaffold for periodontal tissue engineering. Biomaterials. 2007;28:1515-
1522. DOI: 10.1016/j.biomaterials.2006.11.040
Potentials of Polyphenols in Bone-Implant Devices
http://dx.doi.org/10.5772/intechopen.76319
91
[104] Koo K-T, Susin C, Wikesjö UME, Choi S-H, Kim C-K. Transforming growth factor-
beta1 accelerates resorption of a calcium carbonate biomaterial in periodontal defects. 
Journal of Periodontology. 2007;78:723-729. DOI: 10.1902/jop.2007.060336
[105] Jin QM, Anusaksathien O, Webb SA, Rutherford RB, Giannobile WV. Gene ther-
apy of bone morphogenetic protein for periodontal tissue engineering. Journal of 
Periodontology. 2003;74:202-213. DOI: 10.1902/jop.2003.74.2.202
[106] Bascones-Martínez A, Muñoz-Corcuera M, Noronha S, Mota P, Bascones-Ilundain 
C, Campo-Trapero J. Host defence mechanisms against bacterial aggression in peri-
odontal disease: Basic mechanisms. Medicina Oral, Patología Oral y Cirugía Bucal. 
2009;14:10.4317/medoral.14.e680
[107] Roodman GD. Cell biology of the osteoclast. Experimental Hematology. 1999;27:1229-
1241. DOI: 10.1016/S0301-472X(99)00061-2
[108] Ross FP, Osteoclast Biology and Bone Resorption. In: Prim. Metab. Bone Dis. Disord. 
Miner. Metab. Seventh Ed.; 2009: pp. 16-22. DOI: 10.1002/9780470623992.ch3
[109] Boyle WJ, Scott Simonet W, Lacey DL. Osteoclast differentiation and activation. Nature. 
2003;423:337-342. DOI: 10.1038/nature01658
[110] Stabholz A, Soskolne WA, Shapira L. Genetic and environmental risk factors for chronic 
periodontitis and aggressive periodontitis. Periodontology 2000. 2010;2000(53):138-153. 
DOI: 10.1111/j.1600-0757.2010.00340.x
[111] Yoshie H, Kobayashi T, Tai H, Galicia JC. The role of genetic polymorphisms in periodon-
titis. Periodontology 2000. 2007;2000, 43:102-132. DOI: 10.1111/j.1600-0757.2006.00164.x
[112] Zhang J, Sun X, Xiao L, Xie C, Xuan D, Luo G. Gene polymorphisms and periodontitis. 
Periodontology 2000. 2011;2000(56):102-124. DOI: 10.1111/j.1600-0757.2010.00371.x
[113] Donlan RM. Biofilms: Microbial life on surfaces. Emerging Infectious Diseases. 
2002;8:881-890. DOI: 10.3201/eid0809.020063
[114] Ketonis C, Barr S, Adams CS, Hickok NJ, Parvizi J. Bacterial colonization of bone 
allografts: Establishment and effects of antibiotics. Clinical Orthopaedics and Related 
Research. 2010;468:2113-2121. DOI: 10.1007/s11999-010-1322-8
[115] Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. 
Journal of Controlled Release. 2008;130:202-215. DOI: 10.1016/j.jconrel.2008.05.020
[116] Laufenberg G, Kunz B, Nystroem M. Transformation of vegetable waste into value 
added products: (A) the upgrading concept; (B) practical implementations. Bioresource 
Technology. 2003;87:167-198. DOI: 10.1016/S0960-8524(02)00167-0
[117] Vatai T, Škerget M, Knez Ž. Extraction of phenolic compounds from elder berry and dif-
ferent grape marc varieties using organic solvents and/or supercritical carbon dioxide. 
Journal of Food Engineering. 2009;90:246-254. DOI: 10.1016/j.jfoodeng.2008.06.028
[118] Downey MO, Hanlin RL. Comparison of ethanol and acetone mixtures for extraction of 
condensed tannin from grape skin, South African. Journal of Enology and Viticulture. 
2010;31:154-159
Polyphenols92
[119] Kallithraka S, Garcia-Viguera C, Bridle P, Bakker J. Survey of solvents for the extrac-
tion of grape seed phenolics. Phytochemical Analysis. 1995;6:265-267. DOI: 10.1002/
pca.2800060509
[120] Handa K, Saito M, Tsunoda A, Yamauchi M, Hattori S, Sato S, Toyoda M, Teranaka T, 
Narayanan AS. Progenitor cells from dental follicle are able to form Cementum matrix 
in vivo. Connective Tissue Research. 2002;43:406-408. DOI: 10.1080/03008200290001023
[121] Shi J, Yu J, Pohorly J, Young JC, Bryan M, Wu Y. Optimization of the extraction of 
polyphenols from grape seed meal by aqueous ethanol solution. Journal of Food, 
Agriculture and Environment. 2003;1:42-47
[122] González-Manzano S, Rivas-Gonzalo JC, Santos-Buelga C. Extraction of flavan-3-ols 
from grape seed and skin into wine using simulated maceration. Analytica Chimica 
Acta. 2004:283-289. DOI: 10.1016/j.aca.2003.10.019
[123] Da Porto C, Porretto E, Decorti D. Comparison of ultrasound-assisted extraction with con-
ventional extraction methods of oil and polyphenols from grape (Vitis vinifera L.) seeds. 
Ultrasonics Sonochemistry. 2013;20:1076-1080. DOI: 10.1016/j.ultsonch.2012.12.002
[124] Dang YY, Zhang H, Xiu ZL. Microwave-assisted aqueous two-phase extraction of pheno-
lics from grape (Vitis vinifera) seed. Journal of Chemical Technology and Biotechnology. 
2014;89:1576-1581. DOI: 10.1002/jctb.4241
[125] Yilmaz EE, Özvural EB, Vural H. Extraction and identification of proanthocyani-
dins from grape seed (Vitis Vinifera) using supercritical carbon dioxide. Journal of 
Supercritical Fluids. 2011;55:924-928. DOI: 10.1016/j.supflu.2010.10.046
[126] Prado JM, Dalmolin I, Carareto NDD, Basso RC, Meirelles AJA, Oliveira JV, Batista 
EAC, Meireles MAA. Supercritical fluid extraction of grape seed: Process scale-up, 
extract chemical composition and economic evaluation. Journal of Food Engineering. 
2012;109:249-257. DOI: 10.1016/j.jfoodeng.2011.10.007
[127] Kammerer D, Claus A, Carle R, Schieber A. Polyphenol screening of pomace from 
red and white grape varieties (Vitis vinifera L.) by HPLC-DAD-MS/MS. Journal of 
Agricultural and Food Chemistry. 2004;52:4360-4367. DOI: 10.1021/jf049613b
[128] Teixeira A, Baenas N, Dominguez-Perles R, Barros A, Rosa E, Moreno DA, Garcia-
Viguera C. Natural bioactive compounds from winery by-products as health promot-
ers: A review. International Journal of Molecular Sciences. 2014;15:15638-15678. DOI: 
10.3390/ijms150915638
[129] Peralbo-Molina Á, Luque deCastro MD. Potential of residues from the Mediterranean 
agriculture and agrifood industry. Trends in Food Science and Technology. 2013;32:16-
24. DOI: 10.1016/j.tifs.2013.03.007
[130] King M, Chatelain K, Farris D, Jensen D, Pickup J, Swapp A, O’Malley S, Kingsley 
K. Oral squamous cell carcinoma proliferative phenotype is modulated by proan-
thocyanidins: A potential prevention and treatment alternative for oral cancer. BMC 
Complementary and Alternative Medicine. 2007;7. DOI: 10.1186/1472-6882-7-22
Potentials of Polyphenols in Bone-Implant Devices
http://dx.doi.org/10.5772/intechopen.76319
93
[131] Houde V, Grenier D, Chandad F. Protective effects of grape seed proanthocyanidins 
against oxidative stress induced by lipopolysaccharides of periodontopathogens. 
Journal of Periodontology. 2006;77:1371-1379. DOI: 10.1902/jop.2006.050419
[132] Hirasawa M, Takada K, Makimura M, Otake S. Improvement of periodontal status 
by green tea catechin using a local delivery system: A clinical pilot study. Journal of 
Periodontal Research. 2002;37:433-438 doi:1o640 [pii]
[133] Sakanaka S, Okada Y. Inhibitory effects of green tea polyphenols on the produc-
tion of a virulence factor of the periodontal-disease-causing anaerobic bacterium 
Porphyromonas gingivalis. Journal of Agricultural and Food Chemistry. 2004;52:1688-
1692. DOI: 10.1021/jf0302815
[134] Kushiyama M, Shimazaki Y, Murakami M, Yamashita Y. Relationship between intake 
of green tea and periodontal disease. Journal of Periodontology. 2009;80:372-377. DOI: 
10.1902/jop.2009.080510
[135] La VD, Bergeron C, Gafner S, Grenier D. Grape seed extract suppresses lipopolysaccha-
ride-induced matrix metalloproteinase (MMP) secretion by macrophages and inhibits 
human MMP-1 and -9 activities. Journal of Periodontology. 2009;80:1875-1882. DOI: 
10.1902/jop.2009.090251
[136] Han B, Jaurequi J, Tang BW, Nimni ME. Proanthocyanidin: A natural crosslinking reagent 
for stabilizing collagen matrices. Journal of Biomedical Materials Research. Part A. 
2003;65:118-124. DOI: 10.1002/jbm.a.10460
[137] Natarajan V, Krithica N, Madhan B, Sehgal PK. Preparation and properties of tannic 
acid cross-linked collagen scaffold and its application in wound healing. The Journal 
of Biomedical Materials Research Part B: Applied Biomaterials. 2013;101:560-567. DOI: 
10.1002/jbm.b.32856
[138] Iviglia G, Cassinelli C, Torre E, Morra M. Dreamer: An innovative bone filler paste 
for the treatment of periodontitis, Front. Bioeng. Biotechnol. Conf. Abstr. 10th World 
Biomater. Congr.; 2016. DOI: 10.3389/conf.FBIOE.2016.01.01936
[139] Morra M, Cassinelli C, Bollati D, Iviglia G. Compositions for Filling Bone and Perio-
dontal Defects, US20160184191A1, 2016
[140] Harrington DJ. Bacterial collagenases and collagen-degrading enzymes and their 
potential role in human disease. Infection and Immunity. 1996;64:1885-1891
[141] Page RC. The role of inflammatory mediators in the pathogenesis of periodontal dis-
ease. Journal of Periodontal Research. 1991;26:230-242. DOI: 10.1111/j.1600-0765.1991.
tb01649.x
[142] Madhan B, Krishnamoorthy G, Rao JR, Nair BU. Role of green tea polyphenols in the 
inhibition of collagenolytic activity by collagenase. International Journal of Biological 
Macromolecules. 2007;41:16-22. DOI: 10.1016/j.ijbiomac.2006.11.013
[143] Jackson JK, Zhao J, Wong W, Burt HM. The inhibition of collagenase induced degra-
dation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin 
Polyphenols94
gallate and epicatechin gallate. Journal of Materials Science. Materials in Medicine. 
2010;21:1435-1443. DOI: 10.1007/s10856-010-4019-3
[144] Quiding-Järbrink M, Smith DA, Bancroft GJ. Production of matrix metalloproteinases 
in response to mycobacterial infection. Infection and Immunity. 2001;69:5661-5670. 
DOI: 10.1128/IAI.69.9.5661-5670.2001
[145] Iviglia G, Cassinelli C, Torre E, Baino F, Morra M, Vitale-Brovarone C. Novel bioc-
eramic-reinforced hydrogel for alveolar bone regeneration. Acta Biomaterialia. 2016;44. 
DOI: 10.1016/j.actbio.2016.08.012
[146] Tonelli P, Duvina M, Barbato L, Biondi E, Nuti N, Brancato L, Delle Rose G. Bone regen-
eration in dentistry. Clinical Cases in mineral and bone metabolism. 2011;8:24-28
[147] Gaviria L, Salcido JP, Guda T, Ong JL. Current trends in dental implants. Journal of 
the Korean Association of Oral and Maxillofacial Surgeons. 2014;40:50. DOI: 10.5125/
jkaoms.2014.40.2.50
[148] Gupta A, Dhanraj M, Sivagami G. Status of surface treatment in endosseous implant: 
A literary overview. Indian Journal of Dental Research. 2010;21:433-438. DOI: 
10.4103/0970-9290.70805
[149] Grade S, Heuer W, Strempel J, Stiesch M. Structural analysis of in situ biofilm for-
mation on oral titanium implants. Journal of Dental Implants. 2011;1:7. DOI: 
10.4103/0974-6781.76425
[150] Aranya AK, Pushalkar S. Antibacterial and bioactive coatings on titanium implant 
surfaces. Journal of Biomedical Materials Research. Part A. 2017;105:2218-2227. DOI: 
10.1038/nature17150.Sequence-dependent
[151] Coppo E, Marchese A. Antibacterial activity of polyphenols. Current Pharmaceutical 
Biotechnology. 2014;15:380-390. DOI: 10.2174/138920101504140825121142
[152] Daglia M. Polyphenols as antimicrobial agents. Current Opinion in Biotechnology. 
2012;23:174-181. DOI: 10.1016/j.copbio.2011.08.007
[153] Slobodníková L, Fialová S, Rendeková K, Kovác J, Mucaji P. Antibiofilm activity of 
plant polyphenols. Molecules. 2016;21:1717. DOI: 10.3390/molecules21121717
[154] Koru O, Toksoy F, Acikel CH, Tunca YM, Baysallar M, Uskudar Guclu A, Akca E, Ozkok 
Tuylu A, Sorkun K, Tanyuksel M, Salih B. In vitro antimicrobial activity of propolis 
samples from different geographical origins against certain oral pathogens. Anaerobe. 
2007;13:140-145. DOI: 10.1016/j.anaerobe.2007.02.001
[155] Yamanaka A, Kimizuka R, Kato T, Okuda K. Inhibitory effects of cranberry juice 
on attachment of oral streptococci and biofilm formation. Oral Microbiology and 
Immunology. 2004;19:150-154. DOI: 10.1111/j.0902-0055.2004.00130.x
[156] Weiss EI, Lev-Dor R, Sharon N, Ofek I. Inhibitory effect of a high-molecular-weight 
constituent of cranberry on adhesion of oral bacteria. Critical Reviews in Food Science 
and Nutrition. 2002;42:285-292. DOI: 10.1080/10408390209351917
Potentials of Polyphenols in Bone-Implant Devices
http://dx.doi.org/10.5772/intechopen.76319
95
[157] Daglia M, Papetti A, Dacarro C, Gazzani G. Isolation of an antibacterial component from 
roasted coffee. Journal of Pharmaceutical and Biomedical Analysis. 1998;18:219-225. 
DOI: 10.1016/S0731-7085(98)00177-0
[158] Chu C, Deng J, Man Y, Qu Y. Green tea extracts Epigallocatechin-3-gallate for different 
treatments. BioMed Research International. 2017;2017. DOI: 10.1155/2017/5615647
[159] Redlich K, Smolen JS. Inflammatory bone loss: Pathogenesis and therapeutic interven-
tion. Nature Reviews. Drug Discovery. 2012;11:234-250. DOI: 10.1038/nrd3669
[160] Blakytny R, Jude EB. Altered molecular mechanisms of diabetic foot ulcers. The Interna-
tional Journal of Lower Extremity Wounds. 2009;8:95-104. DOI: 10.1177/15347346093 
37151
[161] Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic, infec-
tion: Diagnosis and treatment. Clinical Microbiology Reviews. 2001;14:727-752. DOI: 
10.1128/CMR.14.4.727-752.2001
[162] Bodet C, Chandad F, Grenier D. Cranberry components inhibit interleukin-6, interleukin-8, 
and prostaglandin E production by lipopolysaccharide-activated gingival fibroblasts. 
European Journal of Oral Sciences. 2007;115:64-70. DOI: 10.1111/j.1600-0722.2007.004 
15.x
[163] Palaska I, Papathanasiou E, Theoharides TC. Use of polyphenols in periodontal 
inflammation. European Journal of Pharmacology. 2013;720:77-83. DOI: 10.1016/j.
ejphar.2013.10.047
[164] Ammar N, El Diwany A, Osman N, Gaafar S, Amin N. Flavonoids as a possible preven-
tive of dental plaque. Archives of Pharmacal Research. 1990;13:211-213. DOI: 10.1007/
BF02857804
[165] Arweiler NB, Pergola G, Kuenz J, Hellwig E, Sculean A, Auschill TM. Clinical and 
antibacterial effect of an anti-inflammatory toothpaste formulation with Scutellaria 
baicalensis extract on experimental gingivitis. Clinical Oral Investigations. 2011;15:909-
913. DOI: 10.1007/s00784-010-0471-1
[166] Juntavee A, Peerapattana J, Ratanathongkam A, Nualkaew N, Chatchiwiwattana S, 
Treesuwan P. The antibacterial effects of Apacaries gel on Streptococcus mutans : An 
in vitro study. International Journal of Clinical Pediatric Dentistry. 2014;7:77-81. DOI: 
10.5005/jp-journals-10005-1241
[167] Córdoba A, Satué M, Gómez-Florit M, Hierro-Oliva M, Petzold C, Lyngstadaas 
SP, González-Martín ML, Monjo M, Ramis JM. Flavonoid-modified surfaces: 
Multifunctional bioactive biomaterials with osteopromotive, anti-inflammatory, and 
anti-fibrotic potential. Advanced Healthcare Materials. 2015;4:540-549. DOI: 10.1002/
adhm.201400587
[168] Córdoba A, Satué M, Gómez-florit M, Monjo M, Ramis JM. Flavonoid coated titanium 
surfaces for bioactive bone implants. Stem Cell and Translational Investigation. 2015:2-5. 
DOI: 10.14800/scti.520
Polyphenols96
[169] He L, Deng D, Zhou X, Cheng L, Ten Cate JM, Li J, Li X, Crielaard W. Novel tea polyphe-
nol-modified calcium phosphate nanoparticle and its remineralization potential. The 
Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2015;103:1525-
1531. DOI: 10.1002/jbm.b.33333
[170] Córdoba A, Monjo M, Hierro-Oliva M, González-Martín ML, Ramis JM. Bioinspired 
Quercitrin Nanocoatings: A fluorescence-based method for their surface quantification, 
and their effect on stem cell adhesion and differentiation to the Osteoblastic lineage. 
ACS Applied Materials & Interfaces. 2015;7:16857-16864. DOI: 10.1021/acsami.5b05044
[171] Cazzola M, Ferraris S, Bertone E. Surface functionalisation of biomaterials with plant-
derived biomolecules for bone contact applications. The Bone & Joint Journal. 2017;105: 
99-NaN
[172] Rodriguez R, Kondo H, Nyan M, Hao J, Miyahara T, Ohya K, Kasugai S. Implantation of 
green tea catechin a-tricalcium phosphate combination enhances bone repair in rat skull 
defects. The Journal of Biomedical Materials Research Part B: Applied Biomaterials. 
2011;98(B):263-271. DOI: 10.1002/jbm.b.31848
[173] Li Y, Dånmark S, Edlund U, Finne-Wistrand A, He X, Norgård M, Blomén E, Hultenby 
K, Andersson G, Lindgren U. Resveratrol-conjugated poly-ε-caprolactone facilitates 
in vitro mineralization and in vivo bone regeneration. Acta Biomaterialia. 2011;7:751-
758. DOI: 10.1016/j.actbio.2010.09.008
[174] Varoni EM, Iriti M, Rimondini L. Plant products for innovative biomaterials in den-
tistry. Coatings. 2012;2:179-194. DOI: 10.3390/coatings2030179
[175] Santin M, Morris C, Standen G, Nicolais L, Ambrosio L. A new class of bioactive and 
biodegradable soybean-based bone fillers. Biomacromolecules. 2007;8:2706-2711. DOI: 
10.1021/bm0703362
[176] Merolli A, Nicolais L, Ambrosio L, Santin M. A degradable soybean-based biomaterial 
used effectively as a bone filler in vivo in a rabbit. Biomedical Materials. 2010;5:15008. 
DOI: 10.1088/1748-6041/5/1/015008
[177] Gkioni K, Leeuwenburgh SCG, Douglas TEL, Mikos AG, Jansen JA. Mineralization of 
hydrogels for bone regeneration. Tissue Engineering. Part B, Reviews. 2010;16:577-585. 
DOI: 10.1089/ten.teb.2010.0462
[178] Douglas TEL, Dokupil A, Reczyńska K, Brackman G, Krok-Borkowicz M, Keppler 
JK, Božič M, Van Der Voort P, Pietryga K, Samal SK, Balcaen L, Van Den Bulcke J, 
Van Acker J, Vanhaecke F, Schwarz K, Coenye T, Pamuła E. Enrichment of enzymati-
cally mineralized gellan gum hydrogels with phlorotannin-rich Ecklonia cava extract 
Seanol®to endow antibacterial properties and promote mineralization. Biomedical 
Materials. 2016;11. DOI: 10.1088/1748-6041/11/4/045015
Potentials of Polyphenols in Bone-Implant Devices
http://dx.doi.org/10.5772/intechopen.76319
97
[179] Lišková J, Douglas TEL, Beranová J, Skwarczyńska A, Božič M, Samal SK, Modrzejewska 
Z, Gorgieva S, Kokol V, Bačáková L. Chitosan hydrogels enriched with polyphenols: 
Antibacterial activity, cell adhesion and growth and mineralization. Carbohydrate 
Polymers. 2015;129:135-142. DOI: 10.1016/j.carbpol.2015.04.043
[180] Jain A, Dixit J, Prakash D. Modulatory effects of Cissus quadrangularis on periodontal 
regeneration by bovine-derived hydroxyapatite in intrabony defects: Exploratory clini-
cal trial. Journal of the International Academy of Periodontology. 2008;10:59-65
[181] Kim H-Y, Kim C-S. The effect of safflower seed extract on periodontal healing of 1-wall 
intrabony defects in beagle dogs. Journal of Periodontology. 2002;73:1457-1466
[182] Song W-S, Kim C-S. The effects of a bioabsorbable barrier membrane containing saf-
flower seed extracts on periodontal healing of 1-wall Intrabony defects in beagle dogs. 
Journal of Periodontology. 2005;76:22-33
Polyphenols98
